Drug Database
SU

sumatriptan succinate (Zelrix / NP101 / Zecuity)

✓ Approved

Nupathe Inc. · HTR1D · Small Molecule

What is sumatriptan succinate?

sumatriptan succinate is a small molecule developed by Nupathe Inc.. It is approved for therapeutic indications via topical or transdermal.

Drug Profile

Brand NamesZelrix, NP101, Zecuity
CompanyNupathe Inc.
Drug ClassSmall Molecule
Molecular TargetHTR1D
RouteTopical, Transdermal
StatusApproved

Mechanism of Action

Molecular Targets

sumatriptan succinate acts on 1 molecular target:

HTR1D5-hydroxytryptamine receptor 1D (HTR1DA, HT1DA)
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

sumatriptan succinate is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Nervous system disordersMigraine✓ Approved

Related Research Articles

PubMedToxicology2026-08-30

Transfluthrin: a household insecticide alters glucose metabolism, mitochondrial function and induces atrophy in C2C12 myotubes.

Sharma Onkar O, Devi Rumi R, Sharma Sachin S, Dua Anita A et al.

Non-communicable diseases (NCDs) are increasing globally. Numerous studies have associated pesticide exposure with metabolic alterations in skeletal muscle and the development of related NCDs. Transfluthrin (TF), a volatile type-I pyrethroid insecticide, is widely used as a household mosquito repellent. Although effective in preventing mosquito-borne diseases, recent in vitro and in vivo studies have implicated it in oxidative stress and genotoxic effects. However, its effects on skeletal muscle remain poorly characterized. This study investigated the dose-dependent subtoxic effects of TF on skeletal muscle cell integrity using C2C12 myotubes. Subtoxic concentrations (10µM, 25µM, and 50µM) were selected via MTT assay, and cultured myotubes were exposed to TF for 24h. Along with altered morphology, TF-treated myotubes showed a dose-dependent increase in glucose consumption and uptake. TF disrupted glucose metabolism, as evidenced by reduced glycogen storage and elevated lactate production. In addition, mitochondrial dysfunction was confirmed by decreased MTT reduction, reduced succinate dehydrogenase activity, and membrane depolarization. TF induced oxidative stress, reflected by increased reactive oxygen species (ROS) lipid peroxidation (LPO), and catalase activity, along with reduced glutathione (GSH) levels in treated myotubes. Immunostaining further revealed myotube atrophy in TF-treated myotubes, associated with increased calpain activity and MuRF-1 protein expression. This study demonstrates, for the first time, that TF directly impairs skeletal muscle cell metabolism by inducing oxidative stress, mitochondrial dysfunction, atrophy, and altered glucose utilization, highlighting under-recognized health risks associated with excessive routine household insecticide exposure.

PubMedFood & function2026-08-30

Effects of γ-aminobutyric acid-rich fermented rice bran on hepatic histology, gut microbiota, and fecal metabolites in a rat model of high-fat diet-induced NAFLD-like hepatic injury.

Huang Yuh-Ting YT, Fu Lu-Chi LC, Chen Yi-Hsiu YH, Xiao Qian Q et al.

γ-Aminobutyric acid (GABA)-rich fermented rice bran (GFRB) is a multi-component fermented food matrix with potential metabolic benefits, but its effects on high-fat diet (HFD)-induced liver injury and associated gut microbial and metabolic changes remain unclear. In this study, we characterized the metabolite profile of GFRB and evaluated its effects in rats with HFD-induced liver injury. Male Sprague-Dawley rats were fed a control diet or HFD with or without GABA or low- or high-dose GFRB supplementation for 12 weeks. Gut microbiota, fecal short-chain fatty acids, and fecal metabolomic profiles were further analyzed as exploratory outcomes. GFRB contained markedly increased GABA and was enriched in amino acid- and fermentation-related metabolites, including glutamine, ornithine, citrulline, lactate, and succinate. HFD feeding induced a relatively mild non-alcoholic fatty liver disease-like phenotype characterized by hepatic histopathological alterations, including fatty changes and inflammation. GFRB supplementation attenuated these hepatic alterations, as reflected by a reduced NAFLD activity score in the low-dose GFRB group and decreased hepatic interleukin-6 levels in the high-dose GFRB group. Exploratory analyses also identified alterations in gut microbiota composition and fecal metabolite profiles, particularly in amino acid- and nitrogen-related metabolic pathways. Overall, these findings suggest that GFRB may attenuate early HFD-induced liver injury, potentially through modulation of hepatic inflammation. The accompanying gut microbiota and metabolomic changes should be considered exploratory observations that warrant further mechanistic investigation.

PubMedBioorganic chemistry2026-08-29

A Pyrazole-Amide-Azobenzene scaffold for the photocontrollable modulation of succinate dehydrogenase: synthesis, photophysical and biological properties.

Hu Haoran H, Tang Wenbin W, Li Jiayu J, Wei Siyi S et al.

Aiming to resolve the issues resulting from the widespread use of antifungal in agricultural production, a series of novel Pyrazole-Amides-Azobenzenes (PAAs) has been designed and synthesized by incorporating the photochromic azobenzene moiety into the pharmacophore, endowing them with both antifungal and photoswitching properties. The majority of compounds (especially target compounds A3 and A4) achieved visible light-induced transition from the trans-isomer to cis-isomer. In addition, the in vitro inhibitory activity of compound A3 against Phytophthora capsici increased from an initial 64.2% (trans-isomer) to 89.2% (cis-isomer enriched) with irradiation of 410 nm light. Following the combined enzyme inhibition assays, molecular docking simulations, and molecular dynamics simulation (MD) indicate that these compounds function as ligands targeting succinate dehydrogenase (SDH), exhibiting pronounced differences in enzyme inhibition efficacy between the cis- and trans-isomers. Notably, compounds A3 and A4 exhibited moderate SDH inhibition and low toxicity (against HK-2) in the absence of light irradiation, whereas their inhibitory activity against SDH and toxicity (against HK-2) were significantly enhanced upon irradiation at 410 nm. In addition, zebrafish embryo hatching research have demonstrated that both the trans and cis isomers of compound A4 exhibit low toxicity. Consequently, this light-controlled pharmacological behavior provides practical evidence supporting the application of the PAAs scaffold as a targeted succinate dehydrogenase inhibitor (SDHI) in agricultural production.

PubMedPreventive nutrition and food science2026-08-29

Purple Potato and Its Polyphenols Modulate Cecal Fermentation in Rats.

Chiba Miku M, Kilua Aldrine A, Nagata Ryuji R, Shimada Kenichiro K et al.

This study investigated the effects of the purple potato (PP) cultivar (cv.) 'Shadow-Queen,' rich in polyphenols and resistant starch (RS), on cecal fermentation in rats. It compared such effects with those obtained with a white potato (WP) cv. 'Toyoshiro,' and polyphenol-removed (decolorized purple potato, DPP) 'Shadow-Queen' potatoes. Seven-week-old male Fischer rats were fed diets containing WP, PP, or DPP. Compared to the cecal microbial composition of the control (CON), WP, and DPP groups, the PP group exhibited higher or lower relative abundances of the phyla Firmicutes or Bacteroidetes, respectively. Unclassified Clostridiales and Lactobacillus were more abundant in the PP than in the CON group. Compared to the other three, cecal succinate and immunoglobulin A (IgA) levels were elevated in the PP group. Compared to the CON group, cecal acetate, n-butyrate, and total short-chain fatty acid (SCFA) concentrations were enhanced in the PP, WP, and DPP groups; total SCFAs were higher in PP than in the WP or DPP groups. These results suggest that potato RS altered the cecal microbiota profile and increased SCFA production; the polyphenols in 'Shadow-Queen' potatoes further modulated the microbiota composition, thereby enhancing SCFA and IgA biosynthesis. Therefore, PPs may exert superior physiological effects compared to WPs due to the combined influence of RS and polyphenols.

PubMedPharmaceutical development and technology2026-08-29

The design and optimization of a chitosan-based lamotrigine-loaded intranasal mucoadhesive nanomicelle solution using response surface methodology and artificial neural networks.

Melamane Siyabonga S, Omoteso Omobolanle A OA, Khamanga Sandile M SM, Walker Roderick B RB

The study aimed to develop and optimize chitosan-based mucoadhesive nanomicelles for intranasal delivery of lamotrigine (LTG), to enhance epilepsy treatment, bypass the blood-brain barrier, and potentially improve brain targeting.LTG-loaded nanomicelles were prepared using thin-film hydration and optimized using a central composite design, response surface methodology, and artificial neural networks. The formulation included D-ɑ-tocopheryl polyethylene glycol succinate, Poloxamer 407, chitosan, and glycerol. Critical quality attributes assessed were micelle size (MS), polydispersity index (PDI), Zeta potential (ZP), pH, LTG content, transmittance, in vitro mucoadhesion, LTG release, and 28-day stability.The MS, PDI, ZP, pH, and LTG content of the optimized mucoadhesive nanomicelles was 31.28 ± 0.34 nm, 0.487 ± 0.00, +31.37 ± 1.97 mV, 4.61 ± 0.01, and 2.89 ± 0.01 mg/mL, respectively. The transmittance was 98.50 ± 0.10%, and significant in vitro mucoadhesion, with reduced migration, was observed for mucin-containing gels. LTG release (96.94% at 6 hours) followed the Higuchi diffusion model, with sufficient LTG released at 40 minutes to potentially reach the minimum effective concentration, based on in vitro release data alone. The formulation remained stable for 28 days at 4 °C and 25 °C.Chitosan-based mucoadhesive nanomicelles are a promising intranasal delivery system for LTG, with the potential for brain targeting, controlled LTG release, and improved epilepsy management.

PubMedJournal of environmental management2026-08-29

Toxic effects and molecular mechanisms of Fluopyram on the liver of zebrafish (Danio rerio).

Hou Yuqing Y, Cheng Bo B, Shi Baihui B, Li Shuhan S et al.

Fluopyram (FLP) is a novel and highly effective succinate dehydrogenase inhibitor (SDHI) fungicide and nematicide. Due to its widespread use in crop disease control, it inevitably enters aquatic environments, where it poses potential threat to aquatic organism safety. However, the ecotoxicological effects of FLP have not been fully elucidated. As a classic aquatic model organism, zebrafish are widely used to investigate the aquatic toxicity of environmental contaminants. In this study, adult zebrafish were exposed to FLP at concentrations of 0.05, 0.1, and 0.5 mg/L for 7, 14, 21, and 28 days to evaluate its effects at the histological, physiological, biochemical, and molecular levels. The results showed that FLP induced oxidative stress, DNA damage, and hepatic injury, inhibited SDH and Complex II activities, and altered the expression of key functional genes associated with mitochondrial respiration, antioxidant, apoptosis, and immunity. Molecular docking revealed that FLP binds to SOD and CAT, thereby disrupting the antioxidant system and exacerbating oxidative stress in zebrafish. Integrated Biomarker Response Index analysis indicated that the highest value (18.87) was observed in the 0.5 mg/L-28 days treatment, suggesting that long-term exposure to high concentrations of FLP poses significant ecological risks. Furthermore, transcriptomic analysis identified numerous differentially expressed genes and enriched signaling pathways, providing mechanistic insight into FLP-induced oxidative stress, mitochondrial and DNA damage, apoptosis, and inflammatory responses. Collectively, these results reveal the toxicity of FLP to adult zebrafish and clarify its potential mechanism of action, which provides an important reference for the ecological risk assessment of FLP in aquatic environments.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about sumatriptan succinate